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“Doctor, my thumb hurts” 
How should you treat these common causes of 
nontraumatic thumb pain? Use this evidence-based 
review as a clinical decision-making guide. 
Among the many possible causes of nontraumatic thumb pain are 3 conditions that primary care phy-sicians are likely to encounter again and again: de 
Quervain’s tenosynovitis (dQT), fi rst carpometacarpal osteo-
arthritis (CMC OA), and trigger thumb (TT). Common as they 
are, however, there are no consensus guidelines for the treat-
ment of these conditions. 
With that in mind, we did a literature search for studies of 
treatments for common causes of nontraumatic thumb pain. 
After reviewing the fi ndings, we developed this evidence-
based summary—and the “bottom line” treatment guide on 
page 331—as an aid to clinical decision making. 
de Quervain’s tenosynovitis: An overuse injury 
dQT is characterized by a gradual onset of pain in the fi rst 
dorsal compartment of the wrist. Th e pain is reproduced on 
physical exam with clenched fi st ulnar deviation of the wrist 
(Finkelstein test) (FIGURE). Th e suspected cause is overuse, 
leading to thickening of the tendons of the fi rst dorsal com-
partment and subsequent resisted gliding of the tendons in 
their fi bro-osseous canal.1
NSAIDs and injection: No better than injection alone 
Conservative treatment of dQT consists of topical or oral 
nonsteroidal anti-infl ammatory drugs (NSAIDs), splinting, 
and corticosteroid injection.1 We identifi ed 2 studies using 
such conservative modalities. Th e fi rst was a randomized 
double-blind, placebo-controlled trial, which found that oral 
NSAIDs combined with corticosteroid injection provided no 
statistically signifi cant benefi t compared with corticosteroid 
injection alone (P=.69).2 Th e second study was a pooled qual-
itative analysis and showed that 83% (n=495) of patients were 
asymptomatic after corticosteroid injection alone.3 Treat-
ment failure in the remaining 17% of patients was attributed 
to poor technique and anatomic variation within the fi rst dor-
sal compartment.
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PRACTICE 
RECOMMENDATIONS
› Do not treat de Quervain’s 
tenosynovitis with a corti-
costeroid injection plus a 
nonsteroidal anti-infl amma-
tory drug; the combination 
is no more eff ective than 
the injection alone. B
› Resection arthroplasty of 
the carpometacarpal (CMC) 
joint is the gold standard 
for surgical treatment of 
thumb CMC osteoarthritis, 
but should be off ered only if 
conservative measures fail. C
› Percutaneous release of 
trigger thumb combined with 
a corticosteroid injection pro-
vides greater symptom relief 
than the injection alone. C
Strength of recommendation (SOR)
    Good-quality patient-oriented 
evidence
     Inconsistent or limited-quality 
patient-oriented evidence
     Consensus, usual practice, 
opinion, disease-oriented 
evidence, case series
A
B
C
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Another arm of the study compared the 
combination of corticosteroid injection and 
splinting with splinting alone, which yielded 61% 
and 14% success rates, respectively. Some pa-
tients were treated with NSAIDs and rest alone, 
but this intervention had a 0% success rate.3
Surgery has a high “cure rate”
Symptoms of dQT of >9 months’ duration 
may not respond as well to conservative 
therapy.4 In such cases—and for patients 
for whom conservative measures bring only 
short-term relief—a surgical referral may be 
the best approach. 
Surgery for dQT, a relatively simple 
procedure in which the sheaths surround-
ing the infl amed tendons at the base of the 
thumb are released to relieve the pain and 
swelling, has uniformly positive results. Th e 
“cure rate”—resolution of symptoms with-
out complications—is reported to be >90%.1 
One researcher found a positive correlation 
between a longer duration (>9 months) of 
preoperative symptoms and increased post-
operative satisfaction (P<.4). 4 
First carpometacarpal OA: Pain, 
deformity, functional impairment 
In a study of patients with joint-specifi c ar-
thritis of the hand, the prevalence of fi rst 
CMC OA was reported at 21%.5 Symptoms 
include pain and deformity that may result 
in signifi cant functional impairment of the 
thumb. Physical fi ndings may include pain 
with palpation and swelling and warmth over 
the dorsal aspect of the CMC joint. Th e “grind 
test”—axial compression with internal and 
external rotation of the CMC joint—should 
reproduce the pain and may demonstrate 
crepitus.6 As with osteoarthritis in general, 
CMC OA radiographic fi ndings do not direct-
ly correlate with the physical exam.
Splinting and physical therapy 
bring considerable relief
Conservative treatment options for CMC OA 
include NSAIDs, physical therapy, splinting, 
and corticosteroid injection. American Col-
lege of Rheumatology guidelines support 
NSAIDs or acetaminophen as a fi rst-line treat-
ment for osteoarthritis pain of the knees and 
hips, but no guidelines specifi cally address 
CMC OA.7 Nor have there been any studies fo-
cused on NSAID therapy for CMC OA. 
One retrospective study (n=130) evalu-
ated splinting the thumb in abduction, and 
found that it reduced symptoms of CMC 
OA by an average of 54% to 61% at 6-month 
follow-up.8 Th e researchers studied the re-
FIGURE 
Finkelstein test for de Quervain’s tenosynovitis
With elbows fl exed to 900, the forearms parallel to each other and the fl oor, and the thumb clenched gently inside a fi st (A), the patient 
drops the hand down (adduction) at the wrist (B). Pain over the fi rst dorsal compartment is considered a positive test.
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sults of splinting in patients with stage 1 or 
2 (mild to moderate) CMC OA vs those with 
stage 3 or 4 (moderate to severe) CMC OA, 
and found no signifi cant diff erence in levels 
of improvement. In another study of patients 
with fi rst CMC OA who were treated with 
splinting and physical therapy for 7 months, 
70% of those who underwent treatment de-
clined subsequent surgery, suggesting symp-
tom improvement.9 
Corticosteroid injections alone for 
CMC OA have had mixed results. One study 
compared corticosteroid injection with saline 
injection (n=40) and reported no diff erence 
at 24 weeks’ posttreatment.10 Another found 
short-term improvement from a corticosteroid 
injection (n=25), as measured on a visual ana-
log scale at 1 month (P<.001), but no signifi cant 
improvement in symptoms after 3 months.11
Consider surgery 
if conservative measures fail 
As with most cases of osteoarthritis, surgery 
for CMC OA should be considered only after 
failure of conservative treatment. Surgical 
treatment options should be individualized, 
depending on the extent of disease. 
❚ Resection arthroplasty of the CMC 
joint is the gold standard for surgical treat-
ment of thumb CMC OA.6 In one small study 
(n=24), researchers found that 90% of pa-
tients were satisfi ed with the outcome after 
15 years.12 Th ere are numerous surgical al-
ternatives, however, and research addressing 
resurfacing, synthetic implants, and spacer 
materials is ongoing.6 
Trigger thumb: 
Swelling, pain, limited motion 
TT, also known as stenosing tenosynovi-
tis, is characterized by swelling, limitation 
of thumb range of motion, and a “catching” 
sensation when the thumb is fl exed. Pain is 
usually referred to the fi rst dorsal compart-
ment of the hand. Th e primary pathology is 
thickening of the A1 pulley, with resultant en-
trapment of the fl exor tendon, thus forming a 
triggering mechanism.13 
Early treatment leads to better response 
Conservative treatment options for TT in-
clude splinting and corticosteroid injection; 
NSAIDs alone have not been found to pro-
vide any benefi t.14 One study found that cor-
ticosteroid injection followed by splinting in 
100 to 150 fl exion for 3 to 12 weeks relieved 
symptoms for 66% of those with any trigger 
digit—but only 50% of patients with TT re-
ported an improvement in symptoms.15 
Overall, patients with TT symptoms for 
<4 months have been found to respond sig-
nifi cantly better to any treatment (P=.01).16 
Th is fi nding may be related to repeat injury 
to the tendon sheath, which leads to chronic 
infl ammation and permanent sheath hyper-
Surgical repair 
of de Quervain’s 
tenosynovitis 
has a “cure rate” 
of >90%. 
Nontraumatic thumb pain: 
A bottom line treatment guide
❚ de Quervain’s tenosynovitis. Initially, corticosteroid injection has been found to be the 
most appropriate fi rst-line treatment for dQT;1,4,5 the addition of an oral nonsteroidal anti- 
infl ammatory drug (NSAID) does not result in any additional benefi t.5 What’s more, oral 
NSAIDs and thumb splinting are not effective.3 Overall, surgical repair has demonstrated the 
greatest success, but it is invasive and costly.1,4 
❚ First carpometacarpal osteoarthritis. There are few valid clinical trials for CMC OA. The 
available evidence, however, suggests starting with NSAIDs and progressing to splinting and 
physical therapy, as needed. Corticosteroid injections provide no long-term pain relief.10,11 As 
with osteoarthritis in general, surgery for CMC OA is usually reserved for patients who fail to 
respond to conservative treatments. 
❚ Trigger thumb. There are various methods and levels of success for trigger digit treatment, 
but few studies specifi cally examining treatment of TT. The evidence suggests starting with 
conservative treatment—corticosteroid injection and splinting—in patients who are opposed 
to surgery.15 Both open and percutaneous surgical release of TT have high success rates, how-
ever, and can be offered at any time.13 
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Early diagnosis 
and treatment 
of trigger thumb 
is important, as 
repeat injury 
leads to chronic 
infl ammation 
and permanent 
hypertrophy and 
scarring of the 
tendon sheath. 
trophy and scarring,16 and highlights the im-
portance of early diagnosis and treatment. 
Limited research has been done on the 
eff ect of corticosteroid injection alone on TT. 
Maneerit et al performed a prospective study 
(n=115) comparing steroid injection alone 
with percutaneous release combined with 
corticosteroid injection, and found that the 
injection alone was successful in improving 
symptoms in 47% of patients.17 (Th e combi-
nation of percutaneous release and steroid 
injection, discussed below, had a much high-
er success rate.) 
A retrospective study of treatment for 
trigger digits demonstrated signifi cant im-
provement with corticosteroid injection in 
patients who did not have diabetes; 52% had 
full resolution and 47% had improvement in 
symptoms (P=.04).18 In contrast, corticoste-
roid injection led to symptom resolution for 
only 32% of patients with diabetes.
Surgery for TT: 
Percutaneous or open release
Surgical treatment options for TT include 
percutaneous or open release. Complications 
of surgical intervention for trigger digits in-
clude infection, digital nerve injury, scarring, 
tenderness, and joint contractures. Nimigan 
et al reported a 99% improvement in symp-
toms and return to activity with open surgical 
release for patients with TT (n=72).18 
In the study by Maneerit et al cited ear-
lier, percutaneous release combined with 
corticosteroid injection had a success rate 
(indicated by decreased pain and triggering) 
of 91%, vs a 47% response rate for the group 
who received corticosteroid injection alone 
(P=.001).17 In another study, 25 patients with 
TT that had failed to respond to conservative 
treatment underwent percutaneous release. 
Th e result: An 84% success rate, as shown by 
a decrease in reported pain on a visual analog 
scale (P<.001), with no digital nerve damage 
reported.13 
Digital nerve damage is more of a con-
cern with percutaneous release than with 
open release, because of the proximity of the 
digital nerves to the A1 pulley.13 Success rates 
for percutaneous release vary from 38% to 
100%, with improvement shown after appro-
priate physician training.13                                JFP
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